Kynurenine Monooxygenase (KMO) Inhibitors for the Treatment of Acute Pancreatitis and Neurodegenerative Disorders

Benzer Materyaller

• Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases
  Yazar:: Zhang, Shaowei, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Dual Leucine Zipper Kinase Inhibitors: Potential Treatments for Neurodegenerative Diseases
  Yazar:: Abdel-Magid, Ahmed F.
  Baskı/Yayın Bilgisi: (2014)
• LRRK2 Kinase Inhibitors as Possible Therapy for Parkinson’s Disease and Other Neurodegenerative Disorders
  Yazar:: Abdel-Magid, Ahmed F.
  Baskı/Yayın Bilgisi: (2019)
• Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
  Yazar:: Hutchinson, Jonathan P., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia,
  Yazar:: Wonodi, Ikwunga, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)